[Immunocorrective therapy of hematologic diseases].
Changes in the immunological parameters have been studied in the course of treatment with antithymocytic globulin and chemotherapeutic preparations included in the treatment protocols for aplastic anemia and acute leukemia. A possibility of determining the optimal immunocorrective agent dosage is demonstrated as related to its effect on the functioning of the immunocompetent cells in vitro.
Shabalin
V N
VN
Serova
L D
LD
D000208:Acute Disease; D000741:Anemia, Aplastic / Q000188:drug therapy / Q000628:therapy; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D006402:Hematologic Diseases / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007938:Leukemia / Q000188:drug therapy / Q000628:therapy; D012397:Rosette Formation
D000961:Antilymphocyte Serum
Immunokorrigiruiushchaia terapiia zabolevaniĭ sistemy krovi.